General Finance Corporation Announces Pricing of “Tack-On” Offering of 8.125% Senior Notes Due 2021
Apr 19, 2017 00:00 am UTC| Business
PASADENA, Calif., April 18, 2017 -- General Finance Corporation (NASDAQ:GFN) (the “Company”) announced today that it has priced a “tack-on” public offering of $5,390,000 in aggregate principal amount of its 8.125%...
Apr 19, 2017 00:00 am UTC| Business
NEW YORK, April 18, 2017 -- Gainey McKenna Egleston announces that a class action lawsuit has been filed against Lion Biotechnologies, Inc. (“Lion Biotechnologies” or the “Company”) (Nasdaq:LBIO) in the United States...
Hazeltree Partners with Federated Investors to Automate Cash Sweeps for Buy-Side Clients
Apr 19, 2017 00:00 am UTC| Business
NEW YORK, LONDON and HONG KONG, April 19, 2017 -- Hazeltree, the leading provider of integrated buy-side treasury management solutions, today announced the addition of Federated Investors to Hazeltree’s fast-growing...
Apr 18, 2017 23:15 pm UTC| Business
ROSEMONT, Ill., April 18, 2017 -- Wintrust Financial Corporation (“Wintrust” or “the Company”) (Nasdaq:WTFC) announced net income of $58.4 million or $1.00 per diluted common share for the first quarter of 2017 compared...
Apr 18, 2017 23:00 pm UTC| Business
NEW YORK, April 18, 2017 -- Safirstein Metcalf LLP announces that a class action complaint was filed against Under Armour, Inc. (NYSE:UA) (NYSE:UAA) (“Under Armour” or “UA”) in the U.S. District Court for the District...
Trilogy International Partners Announces US $345 million Debt Offering
Apr 18, 2017 22:15 pm UTC| Business
BELLEVUE, Wash., April 18, 2017 -- Trilogy International Partners Inc. (TSX:TRL) (“TIP Inc”) today announced that its subsidiaries, Trilogy International Partners LLC (“Trilogy LLC”) and Trilogy International Finance...
Intellipharmaceutics Reports Director Election Results
Apr 18, 2017 22:15 pm UTC| Business
TORONTO, April 18, 2017 -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture...